AUG 31, 2021 9:00 AM PDT

The Regulation of ALC1 by TRIM33 during the DNA Damage Response

Speaker

Abstract
Date:  August 31, 2021
Time: 9:00am (PDT),  12:00pm (EDT)
 
The DNA damage response is extremely crucial in maintaining genomic integrity. Failure to repair damaged DNA can result in the propagation of mutations and lesions that can contribute to tumorigenesis. The poly [ADP-ribose] polymerase (PARP), is a DNA damage response protein that is transiently recruited to sites of DNA breaks, and is involved in the signaling and recruitment of other important DNA damage response proteins. PARP is involved in the regulation of the chromatin remodeling enzyme, Amplified in Liver Cancer 1 (ALC1). ALC1 functions as a chromatin remodeler, and studies from our laboratory has shown that ALC1 interacts with the E3 ubiquitin-protein ligase, Tripartite Motif-containing 33 (TRIM33) during DDR. TRIM33 has been known to play a role in numerous biological process such as tumorigenesis, TGF-B signaling and transcriptional regulation. We have observed that TRIM33 is recruited to sites of DNA breaks after the activation of PARP, and interacts with ALC1. TRIM33-deficient cells have shown to exhibit sensitivity to DNA damage, with the subsequent and prolonged retention of ALC1 at the sites of DNA breaks. Prolonged chromatin relaxation facilitated by ALC1 leads to increased sensitivity to DNA damaging agents. This sensitivity can be overcome with the overexpression of TRIM33. Our laboratory has demonstrated that TRIM33 regulates the activity of ALC1 during DNA repair by facilitating the timely removal of ALC1 at the sites of DNA breaks, thus promoting efficient DNA repair. There is current research focus that aims to investigate the dynamics of TRIM33 and ALC1, and their interactions with other key proteins involved in DNA repair, especially those proteins that are differentially regulated.
 
Learning Objectives
 
  • Describe and understand the mechanisms of DNA Repair
  • Discuss how the PARP dependent DNA damage response pathway is regulated
  • Discuss and understand how key proteins involved in DDR including TRIM33 and ALC1 can serve as actionable targets in the treatment of certain cancer
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
FEB 15, 2023 7:00 AM PST
FEB 15, 2023 7:00 AM PST
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
NOV 09, 2022 8:00 AM PST
C.E. CREDITS
NOV 09, 2022 8:00 AM PST
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
OCT 13, 2022 9:00 AM +08
OCT 13, 2022 9:00 AM +08
First Broadcast: Date: October 12, 2022 Time: 8:00am PDT, 11:00am EDT Second Broadcast: Date: October 12, 2022 Time: 9:00am SGT The new Embedded CryoSPARC Live, now fully integrated with t...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
Loading Comments...
Show Resources